Volltextsuche
Hinweis: Bitte geben Sie einen Suchbegriff ein, z.B. "BMW", um alle Analysen und News über BMW aufgelistet zu bekommen, die innerhalb der Site von AktienCheck vorhanden sind! Zusätzlich können Sie noch eine Zeitspanne auswählen.
Suchergebnisse: (33877 Ergebnisse gefunden) Es w.
| Datum | Thema | |
|---|---|---|
| 03:42 | Xiaomi’s Auto Gamble Deepens: Buyback, Price War, and a Smartphone Slump | |
| The Chinese tech giant is sending mixed signals to the market. On one hand, management is spending 146 million HKD to repurchase 4.7 million of its own B-shares on the Hong Kong exchange, a clear vote of confidence in a stock trading at just 3.39 euros in Germany—barely above its 52-week low. [...] | ||
| 01:35 | Vonovia’s Stock Slips as Two Technical Signals Flash Contradictory Warnings | |
| The Vonovia share price has been caught in a tug-of-war between short-term technical optimism and longer-term fundamental headwinds, with the stock sliding 1.73 percent on Thursday to EUR 23.24. That decline comes just a day after the shares briefly breached a key moving average, only to give back those gains as the broader market mood soured. [...] | ||
| 01:07 | SAP's Slide Weighs on DAX as German Economic Data Darkens the Mood | |
| Infineon's blistering rally proved no match for the weight of SAP's decline Thursday, as Germany's blue-chip index found itself pinned between a tech-sector reassessment and a fresh dose of economic gloom. The DAX closed at 24,155 points, shedding 0.16% on the day after briefly threatening to breach the psychologically important 24,000 threshold. [...] | ||
| 00:14 | Micron's Production Capacity Squeeze Fuels a Market of Its Own Making | |
| The numbers coming out of Micron Technology are rewriting the rulebook for semiconductor investing. The memory chip maker's stock hit an intraday all-time high of roughly $492 on Thursday, closing with an 8.5% gain and bringing its year-to-date advance to around 55%. But the real story lies in what the company cannot do: satisfy demand. [...] | ||
| 23.04.26 | IRW-News: HYTN Innovations Inc.: HYTN kündigt geplante Ausgliederung des Geschäftsbereichs der BPC-157-Peptid-Arzneimittelentwicklung an | |
| IRW-PRESS: HYTN Innovations Inc.: HYTN kündigt geplante Ausgliederung des Geschäftsbereichs der BPC-157-Peptid-Arzneimittelentwicklung an Vancouver, British Columbia, 23. April 2026 / IRW-Press / HYTN Innovations Inc. (CSE: HYTN) (OTC Pink: HYTNF) (FWB: 85W0) (HYTN oder das Unternehmen) gibt bekannt, dass sein Board of Directors die Ausgliederung des internen Geschäftsbereichs der Entwicklung von Peptidarzneimitteln in ein eigenes neues Unternehmen (SpinCo) genehmigt hat. [...] | ||
| 23.04.26 | HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business | |
| VANCOUVER, British Columbia, April 23, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN) (OTC Pink: HYTNF) (FSE: 85W0) ("HYTN" or the "Company") announces that its Board of Directors has approved the spin-out of an internally developed peptide drug development business into a dedicated new company ("SpinCo"). [...] | ||
| 23.04.26 | Parker Increases Quarterly Cash Dividend 11% to $2.00 per Share | |
| CLEVELAND, April 23, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that its Board of Directors has declared a quarterly cash dividend of $2.00 per share of common stock to shareholders of record as of May 8, 2026. [...] | ||
| 23.04.26 | Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors | |
| Appointment strengthens Board’s clinical development and regulatory expertise as Vaxart advances its oral vaccine platform. [...] | ||
| 23.04.26 | ONEOK Declares Quarterly Dividend | |
| TULSA, Okla., April 23, 2026 (GLOBE NEWSWIRE) -- The board of directors of ONEOK, Inc. (NYSE: OKE) today declared a quarterly dividend of $1.07 per share, unchanged from the previous quarter, resulting in an annualized dividend of $4.28 per share.. [...] | ||
| 23.04.26 | Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors | |
| WATERTOWN, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). [...] |
